MeiraGTx Holdings (MGTX) Cash from Investing Activities (QoQ) (2017 - 2025)
MeiraGTx Holdings (MGTX) Cash from Investing Activities (QoQ) (2017 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | MeiraGTx Holdings | 997.33 Mn | 931.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -99.09% |
| Sep 30, 2025 | 28.12% |
| Jun 30, 2025 | 55.50% |
| Mar 31, 2025 | -40.39% |
| Dec 31, 2024 | 7.31% |
| Sep 30, 2024 | 1.13% |
| Jun 30, 2024 | -104.86% |
| Mar 31, 2024 | -46.58% |
| Dec 31, 2023 | 1,535.97% |
| Sep 30, 2023 | 28.36% |
| Jun 30, 2023 | 42.18% |
| Mar 31, 2023 | -1.33% |
| Dec 31, 2022 | 15.17% |
| Sep 30, 2022 | 28.49% |
| Jun 30, 2022 | -12.36% |
| Mar 31, 2022 | 50.88% |
| Dec 31, 2021 | -113.10% |
| Sep 30, 2021 | -113.54% |
| Jun 30, 2021 | 70.45% |
| Mar 31, 2021 | -84.37% |